Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 34

    1.

    The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects.

    Ota S, Zhou ZQ, Link JM, Hurlin PJ.

    Hum Mol Genet. 2009 Jul 15;18(14):2609-21. Epub 2009 Apr 29.PMID: 19403560 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Development of human gene reporter cell lines using rAAV mediated homologous recombination.

    Fernandez SL, Russell DW, Hurlin PJ.

    Biol Proced Online. 2007 Dec 24;9:84-90.PMID: 18464937 [PubMed - in process]Related articlesFree article

    3.

    Activities of N-Myc in the developing limb link control of skeletal size with digit separation.

    Ota S, Zhou ZQ, Keene DR, Knoepfler P, Hurlin PJ.

    Development. 2007 Apr;134(8):1583-92. Epub 2007 Mar 14.PMID: 17360777 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The MAX-interacting transcription factor network.

    Hurlin PJ, Huang J.

    Semin Cancer Biol. 2006 Aug;16(4):265-74. Epub 2006 Jul 14. Review.PMID: 16908182 [PubMed - indexed for MEDLINE]Related articles

    5.

    Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.

    Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A.

    Cancer Res. 2006 Jun 1;66(11):5565-73. Erratum in: Cancer Res. 2006 Jul 1;66(13):6894. Lozach, Laure Escoubet [corrected to Escoubet-Lozach, Laure]; Bassett, Ivan Garcia [corrected to Garcia-Bassets, Ivan]. PMID: 16740691 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.

    Dezfouli S, Bakke A, Huang J, Wynshaw-Boris A, Hurlin PJ.

    Mol Cell Biol. 2006 Mar;26(6):2080-92.PMID: 16507988 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    N-Myc functions in transcription and development.

    Hurlin PJ.

    Birth Defects Res C Embryo Today. 2005 Dec;75(4):340-52. Review.PMID: 16425253 [PubMed - indexed for MEDLINE]Related articles

    8.

    Of Myc and Mnt.

    Hooker CW, Hurlin PJ.

    J Cell Sci. 2006 Jan 15;119(Pt 2):208-16. Review.PMID: 16410546 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mnt transcriptional repressor is functionally regulated during cell cycle progression.

    Popov N, Wahlström T, Hurlin PJ, Henriksson M.

    Oncogene. 2005 Dec 15;24(56):8326-37.PMID: 16103876 [PubMed - indexed for MEDLINE]Related articles

    10.

    Mnt-Max to Myc-Max complex switching regulates cell cycle entry.

    Walker W, Zhou ZQ, Ota S, Wynshaw-Boris A, Hurlin PJ.

    J Cell Biol. 2005 May 9;169(3):405-13. Epub 2005 May 2.PMID: 15866886 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Functions of myc:max in the control of cell proliferation and tumorigenesis.

    Hurlin PJ, Dezfouli S.

    Int Rev Cytol. 2004;238:183-226. Review.PMID: 15364199 [PubMed - indexed for MEDLINE]Related articles

    12.

    Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome.

    Toyo-oka K, Hirotsune S, Gambello MJ, Zhou ZQ, Olson L, Rosenfeld MG, Eisenman R, Hurlin P, Wynshaw-Boris A.

    Hum Mol Genet. 2004 May 15;13(10):1057-67. Epub 2004 Mar 17.PMID: 15028671 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Evidence of mnt-myc antagonism revealed by mnt gene deletion.

    Hurlin PJ, Zhou ZQ, Toyo-Oka K, Ota S, Walker WL, Hirotsune S, Wynshaw-Boris A.

    Cell Cycle. 2004 Feb;3(2):97-9. Review.PMID: 14712062 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

    Hurlin PJ, Zhou ZQ, Toyo-oka K, Ota S, Walker WL, Hirotsune S, Wynshaw-Boris A.

    EMBO J. 2003 Sep 15;22(18):4584-96.PMID: 12970171 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.

    Carlson H, Ota S, Song Y, Chen Y, Hurlin PJ.

    Oncogene. 2002 May 30;21(24):3827-35.PMID: 12032820 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.
    17.

    The interplay between Mad and Myc in proliferation and differentiation.

    Zhou ZQ, Hurlin PJ.

    Trends Cell Biol. 2001 Nov;11(11):S10-4. Review.PMID: 11684436 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.

    Hurlin PJ, Steingrìmsson E, Copeland NG, Jenkins NA, Eisenman RN.

    EMBO J. 1999 Dec 15;18(24):7019-28. Erratum in: EMBO J 2000 Jul 17;19(14):3841. PMID: 10601024 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Analysis of the Max-binding protein MNT in human medulloblastomas.

    Sommer A, Waha A, Tonn J, Sörensen N, Hurlin PJ, Eisenman RN, Lüscher B, Pietsch T.

    Int J Cancer. 1999 Sep 9;82(6):810-6.PMID: 10446446 [PubMed - indexed for MEDLINE]Related articles

    20.

    The Mad protein family links transcriptional repression to cell differentiation.

    McArthur GA, Laherty CD, Quéva C, Hurlin PJ, Loo L, James L, Grandori C, Gallant P, Shiio Y, Hokanson WC, Bush AC, Cheng PF, Lawrence QA, Pulverer B, Koskinen PJ, Foley KP, Ayer DE, Eisenman RN.

    Cold Spring Harb Symp Quant Biol. 1998;63:423-33. Review. No abstract available. PMID: 10384307 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...